Highlights
Highlights
❰❱
Actualités
EANS-News: RHI AG / RHI publishes reorganization documentation ? probability of the planned combination with Magnesita has increased
issuer: RHI AG Wienerbergstrasse 9 A-1100 Wien phone: +43-1-50213-6676 FAX: mail: investor.relations@rhi-ag.com WWW: http://www.rhi-ag.com ISIN: AT0000676903 indexes: ATX stockmarkets: Wien language: English ...
plusRenault-Nissan Alliance Executives Elected to Avtovaz Board of Directors at Annual General Shareholders Meeting
Paris (ots/PRNewswire) - - The 2016 Annual Report of PJSC "AVTOVAZ" and the new composition of its Board of Directors have been approved. - AVTOVAZ Group on track to financial recovery in 2018. Executives from the Renault-Nissan Alliance were elected to AVTOVAZ Board of Directors during its Annual General ...
plusDebiopharm International SA and Arbor Pharmaceuticals, LLC Announce U.S. FDA Approval for Triptodur(TM), Triptorelin 6-month Formulation, in the Treatment of Central Precocious Puberty (CPP)
Lausanne, Switzerland and Atlanta, GA (ots) - Triptodur (TM), (triptorelin) for extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty with once every six-month intramuscular injection (IM) dosing for children with CPP Approval brings new CPP treatment formulation ...
plusALK: Five-year GRAZAX® Asthma Prevention (GAP) Trial Reveals Benefits of Early Treatment Intervention in Children
Hørsholm, Denmark (ots/PRNewswire) - - The disease modifying property of GRAZAX® (SQ® grass SLIT-tablet) resulted in long-term effect on allergic rhinoconjunctivitis (ARC) and prevented asthma symptoms, even two years after end of treatment in children with grass pollen ARC and no existing signs or symptoms of ...
plusAtradius Collections Releases the 11th Edition of the Insight-packed International Debt Collections Handbook
Amsterdam (ots/PRNewswire) - Atradius Collections' International Debt Collections Handbook explains the different stages of amicable settlement, laws around collections, legal proceedings and insolvency procedures across 44 of the world's countries. Argentina and Morocco are two new countries featured in this ...
plusKfW creates subsidiary for equity finance
Frankfurt am Main (ots) - - Move is to strengthen Germany as a location for start-ups and fast-growing innovative technology firms - Planned investment volume of EUR 2 billion over the next 10 years - Subsidiary is scheduled to be founded in early 2018 and commence operations in the middle of the year In the years ahead, KfW will substantially expand its activities in the field of equity finance. For this purpose it will ...
plus
EQS-News: Zur Rose Group AG announces narrowed price range and shortens the book-building period
EQS Group-News: Zur Rose Group AG / Key word(s): IPO Zur Rose Group AG announces narrowed price range and shortens the book-building period 30.06.2017 / 07:00 588037 30.06.2017 ...
plusTeenagers and Higher-Income Households Most Likely to Struggle with Technology Addiction, Shows GfK Survey
Nuremberg, Germany (ots/PRNewswire) - - One in three people find it difficult to take a break from technology, even when they know they should - China, Brazil and Argentina have highest levels who struggle to take a tech break - People in Germany, The Netherlands and Belgium lead for finding it easy to 'unplug' A ...
plusEQS-Adhoc: LifeWatch AG: LifeWatch publishes invitation to an Extraordinary General Meeting
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): AGM/EGM LifeWatch AG: LifeWatch publishes invitation to an Extraordinary General Meeting 29-Jun-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 587251 29-Jun-2017 CET/CEST ...
plusEQS-Adhoc: LifeWatch AG: BioTelemetry releases provisional end result of public offer for LifeWatch
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: BioTelemetry releases provisional end result of public offer for LifeWatch 29-Jun-2017 / 06:58 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 587419 29-Jun-2017 CET/CEST ...
plusGenePOC Announces an Exclusive Distribution Agreement with Cardinal Health covering the US market
Québec, Canada (ots) - GenePOC announces the signing of an exclusive distribution agreement with Cardinal Health to become its commercial partner in the United States. GenePOC, Inc. (GenePOC), a member of the Debiopharm Group, is proud to announce that it has signed an exclusive distribution agreement with Cardinal ...
plusDGAP-Adhoc: LION E-Mobility AG: LION Smart GmbH signs exclusive supply agreement for its battery management system with Kreisel Electric GmbH
DGAP-Ad-hoc: LION E-Mobility AG / Key word(s): Incoming Orders/Alliance LION E-Mobility AG: LION Smart GmbH signs exclusive supply agreement for its battery management system with Kreisel Electric GmbH 27-Jun-2017 / 15:50 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a ...
plus
World Innovation Summit for Education (WISE)
2017 WISE Awards Finalists Announced
Doha, Qatar (ots/PRNewswire) - Fifteen projects from nine countries have been selected by the World Innovation Summit for Education (WISE) for innovative and impactful approaches to today's most urgent education challenges The World Innovation Summit for Education (WISE) announced the 15 2017 WISE Awards finalist projects. Each year, the WISE Awards recognize and promote innovative projects from around the world that are ...
plusEthicon Launches New Power Stapler Enabling Extra Control and Precision for Complex Surgeries
Norderstedt, Germany (ots/PRNewswire) - The ECHELON FLEX(TM) GST System now features a 45mm endocutter intended for use in very thick tissue[5], making it suitable across a range of specialties Building on the success of the ECHELON FLEX(TM) 60mm Powered Plus Stapler with Gripping Surface Technology (GST), Ethicon*, a leading global provider of medical devices, today ...
plusEQS-Adhoc: Leclanché SA: Leclanché signs preferred partnership agreement with Skoda Electric to supply 'next generation' electric vehicle solutions
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Contract/Development of Sales Leclanché SA: Leclanché signs preferred partnership agreement with Skoda Electric to supply 'next generation' electric vehicle solutions 26-Jun-2017 / 19:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR ...
plusData Provide Additional Insight Into the Mode of Action of MAVENCLAD(TM) (Cladribine Tablets) in Patients With Relapsing MS
Darmstadt, Germany (ots/PRNewswire) - - Data suggest that MAVENCLAD(TM) (Cladribine Tablets) selectively and discontinuously reduces B and T lymphocytes, with lymphocyte counts returning to normal range before the end of Year 2 - The lymphocyte data presented at EAN Congress are consistent with other clinical safety ...
plusKfW Credit Market Outlook: New lending to businesses shows surprising momentum
Frankfurt am Main (ots) - - New business loans up 3.1% in first quarter of 2017 - With the economy doing well and borrowing costs expected to rise, growing investment confidence is finally boosting demand as well - KfW Research expects the credit market to gain further momentum into summer Estimates by KfW Research indicate that new lending from German banks and ...
plusPhilips Unveils IntelliVue X3 in Europe for Continuous Critical Care Patient Monitoring During In-hospital Transport
Amsterdam (ots/PRNewswire) - New technology integrates seamlessly into IntelliVue Patient Monitoring system to deliver real-time data records and enhance clinical decision support Royal Philips (http://www.philips.com/) (NYSE: PHG AEX: PHIA), a global health technology company, today announced the release of the ...
plus
Long-term outcomes after standard graft-versus-host disease (GvHD) prophylaxis in hemopoietic cell transplantation from matched unrelated donors strongly support the use of Grafalon® as standard therapy
plusMerck to Present Data on MAVENCLAD(TM) (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017
Darmstadt, Germany (ots/PRNewswire) - - New data builds on company's longstanding commitment to MS Merck, a leading science and technology company, will present data from its neurology and immunology portfolio at the 3rd Congress of the European Academy of Neurology (EAN), taking place from June 24-27, in Amsterdam, ...
plusBank of Montreal Announces Specific Share Repurchase Program as Part of its Normal Course Issuer Bid
Toronto (ots/PRNewswire) - Bank of Montreal ("BMO") (TSX: BMO)(NYSE: BMO) today announced that the Toronto Stock Exchange ("TSX") has accepted BMO's amended notice of intention to make a Normal Course Issuer Bid. The notice has been amended to, among other things, permit the repurchase by BMO of its common shares ...
plusEANS-Adhoc: RHI announces Management Board changes
issuer: RHI AG Wienerbergstrasse 9 A-1100 Wien phone: +43 (0)50213-6676 FAX: +43 (0)50213-6130 mail: rhi@rhi-ag.com WWW: http://www.rhi-ag.com ISIN: AT0000676903 indexes: ATX stockmarkets: Wien language: English ...
plusCladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - - Efficacy and safety data support positive benefit/risk assessment from CHMP - Cladribine Tablets is the first and only investigational medicinal product to have shown a sustained 4 years of disease control with a maximum of 20 days of oral treatment over 2 years in clinical ...
plusExperts Call for Urgent Action to Address Surgical Site Infections
Geneva (ots/PRNewswire) - Leading specialists at ICPIC congress come together to discuss the issue of SSIs and recent guidelines regarding the use of triclosan-coated sutures in all types of surgery[6] Ethicon* part of the Johnson & Johnson Medical Devices Companies** has joined leading wound closure specialists to discuss recommendations to ease the burden of surgical site infections (SSIs) on patients and costs to ...
plus
EQS-News: Zur Rose Group AG launches IPO on SIX Swiss Exchange and sets price range
EQS Group-News: Zur Rose Group AG / Key word(s): IPO Zur Rose Group AG launches IPO on SIX Swiss Exchange and sets price range 22.06.2017 / 07:00 585131 22.06.2017 ...
plusShire Pharmaceuticals Group Plc
Shire Announces EMA Validation of Veyvondi[TM] [Von Willebrand Factor (Recombinant)] Marketing Authorization Application for Treatment of Von Willebrand Disease
Zug, Switzerland (ots/PRNewswire) - VEYVONDI is the first and only recombinant von Willebrand factor treatment for adults with von Willebrand disease, the most common inherited bleeding disorder[1],[2],[3] Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare ...
plus70th anniversary of the Marshall Plan - Start-up capital for KfW
Frankfurt am Main (ots) - - 1947: US Secretary of State George C. Marshall launches the "European Recovery Program" (ERP) - 1948: KfW is founded to channel the ERP funds - Promotional business volume of KfW since its foundation totals over EUR 1.5 trillion 2017 marks the seventieth anniversary of the announcement of the Marshall Plan, one of KfW's most significant historical foundations. On behalf of the German Federal ...
plusAlmac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor
Craigavon, N.I., UK, Lausanne, Switzerland (ots) - Almac Discovery (www.almacgroup.com/discovery), a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Debiopharm International SA (Debiopharm - www.debiopharm.com), a Switzerland based specialty ...
plusEQS-Adhoc: Kaufangebot für alle Aktionäre der Linde Holding Biel/Bienne AG: Swiss Medical Network SA erhöht ihr Angebot in bar auf CHF 3'100 infolge der Erhöhung des Gegenangebots von Hirslanden
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Offer Kaufangebot für alle Aktionäre der Linde Holding Biel/Bienne AG: Swiss Medical Network SA erhöht ihr Angebot in bar auf CHF 3'100 infolge der Erhöhung des Gegenangebots von Hirslanden 20-Jun-2017 / 16:25 CET/CEST Release of an ad hoc announcement pursuant ...
plusIUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact(TM) System
Sunnyvale, California (ots/PRNewswire) - The French Cancer Institute is Building its Re-irradiation and Adaptive Radiotherapy Program Using the Latest Technology Developed by Accuray Accuray Incorporated (NASDAQ: ARAY) announced today that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) is providing advanced radiation treatments to cancer patients ...
plus